Polymer Capital Management (HK) LTD
Source: SEC Form 13F · as of Mar 2026Polymer Capital Management (HK) LTD holds 15 biotech & pharma companies tracked by BioSniper, totaling $93.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$93.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 43,435 | $40.0M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 57,784 | $19.1M |
| ERASErasca, Inc. | 357,670 | $5.8M |
| MRKMerck & Co., Inc. | 42,570 | $5.1M |
| IONSIONIS PHARMACEUTICALS INC | 61,200 | $4.6M |
| AVBPArriVent BioPharma, Inc. | 122,276 | $2.8M |
| CRVSCorvus Pharmaceuticals, Inc. | 183,187 | $2.7M |
| MANEVeradermics Incorporated | 41,296 | $2.6M |
| SMMTSummit Therapeutics Inc. | 133,034 | $2.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 8,500 | $2.3M |
| RVMDREVOLUTION MEDICINES, INC. | 23,227 | $2.3M |
| DBVTDBV Technologies S.A. | 64,500 | $1.3M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,259 | $973K |
| NRIXNurix Therapeutics, Inc. | 58,898 | $913K |
| NVONovo Nordisk A/S | 23,328 | $857K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.